Dual-Atom Nanozyme Eye Drops Attenuate Inflammation and Break the Vicious Cycle in Dry Eye Disease

Dandan Chu; Mengyang Zhao; Shisong Rong; Wonho Jhe; Xiaolu Cai; Yi Xiao; Wei Zhang; Xingchen Geng; Zhanrong Li; Xingcai Zhang; Jingguo Li

doi:10.1007/s40820-024-01322-7

[1] J.A. Clayton, Dry eye. N. Engl. J. Med. 378(23), 2212–2223 (2018).

[2] F.E. Hakim, A.V. Farooq, Dry eye disease: An update in 2022. JAMA 327(5), 478–479 (2022).

[3] K. Walter, What is dry eye disease? JAMA 328(1), 84 (2022).

[4] D. Wirta, Update on dry eye disease. JAMA 327(23), 2355–2356 (2022).

[5] S.H. Liu, I.J. Saldanha, A.G. Abraham, T. Rittiphairoj, S. Hauswirth et al., Topical corticosteroids for dry eye. Cochrane Database Syst. Rev. 10, CD015070 (2022).

[6] S.C. Pflugfelder, C.S. de Paiva, The pathophysiology of dry eye disease: what we know and future directions for research. Ophthalmology 124(11), S4–S13 (2017).

[7] W. Ouyang, S. Wang, D. Yan, J. Wu, Y. Zhang et al., The cGAS-STING pathway-dependent sensing of mitochondrial DNA mediates ocular surface inflammation. Signal Transduct. Target. Ther. 8, 371 (2023).

[8] G.S. Shadel, T.L. Horvath, Mitochondrial ROS signaling in organismal homeostasis. Cell 163(3), 560–569 (2015).

[9] Q. Zheng, L. Li, M. Liu, B. Huang, N. Zhang et al., In situ scavenging of mitochondrial ROS by anti-oxidative MitoQ/hyaluronic acid nanoparticles for environment-induced dry eye disease therapy. Chem. Eng. J. 398, 125621 (2020).

[10] H.J. Forman, H. Zhang, Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 20, 689–709 (2021).

[11] R.C. Coll, A.A.B. Robertson, J.J. Chae, S.C. Higgins, R. Muñoz-Planillo et al., A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248–255 (2015).

[12] K.C. Barnett, S. Li, K. Liang, J.P.-Y. Ting, A 360° view of the inflammasome: mechanisms of activation, cell death, and diseases. Cell 186(11), 2288–2312 (2023).

[13] K. Ciazynska, The activated inflammasome. Nat. Struct. Mol. Biol. 30, 125 (2023).

[14] S.H. Baik, V.K. Ramanujan, C. Becker, S. Fett, D.M. Underhill et al., Hexokinase dissociation from mitochondria promotes oligomerization of VDAC that facilitates NLRP3 inflammasome assembly and activation. Sci. Immunol. 8, eade7652 (2023).

[15] S. Li, Z. Lu, Y. Huang, Y. Wang, Q. Jin et al., Anti-oxidative and anti-inflammatory micelles: break the dry eye vicious cycle. Adv. Sci. 9(17), e2200435 (2022).

[16] M.K. Rhee, F.S. Mah, Inflammation in dry eye disease: How do we break the cycle? Ophthalmology 124(11), S14–S19 (2017).

[17] R. Zhou, A.S. Yazdi, P. Menu, J. Tschopp, A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221–225 (2011).

[18] J. Tschopp, K. Schroder, NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10, 210–215 (2010).

[19] L.K. Billingham, J.S. Stoolman, K. Vasan, A.E. Rodriguez, T.A. Poor et al., Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation. Nat. Immunol. 23, 692–704 (2022).

[20] X. Yu, P. Lan, X. Hou, Q. Han, N. Lu et al., HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production. J. Hepatol. 66(4), 693–702 (2017).

[21] Y. Ruan, Y. Xiong, W. Fang, Q. Yu, Y. Mai et al., Highly sensitive curcumin-conjugated nanotheranostic platform for detecting amyloid-beta plaques by magnetic resonance imaging and reversing cognitive deficits of Alzheimer’s disease via NLRP3-inhibition. J. Nanobiotechnology 20, 322 (2022).

[22] Y. Gan, G. Zhao, Z. Wang, X. Zhang, M.X. Wu et al., Bacterial membrane vesicles: physiological roles, infection immunology, and applications. Adv. Sci. 10(25), e2301357 (2023).

[23] H. Xiang, W. Feng, Y. Chen, Single-atom catalysts in catalytic biomedicine. Adv. Mater. 32(8), e1905994 (2020).

[24] J. Li, S. Song, J. Meng, L. Tan, X. Liu et al., 2D MOF periodontitis photodynamic ion therapy. J. Am. Chem. Soc. 143(37), 15427–15439 (2021).

[25] H. Gao, M. Sun, Y. Duan, Y. Cai, H. Dai et al., Controllable synthesis of lignin nanoparticles with antibacterial activity and analysis of its antibacterial mechanism. Int. J. Biol. Macromol. 246, 125596 (2023).

[26] Q. Qu, W. Cheng, X. Zhang, A. Zhou, Y. Deng et al., Multicompartmental microcapsules for enzymatic cascade reactions prepared through gas shearing and surface gelation. Biomacromol 23(9), 3572–3581 (2022).

[27] H. Rashidzadeh, F. Seidi, M. Ghaffarlou, M. Salehiabar, J. Charmi et al., Preparation of alginate coated Pt nanoparticle for radiosensitization of breast cancer tumor. Int. J. Biol. Macromol. 233, 123273 (2023).

[28] A. Madni, R. Kousar, N. Naeem, F. Wahid, Recent advancements in applications of chitosan-based biomaterials for skin tissue engineering. J. Bioresour. Bioprod. 6(1), 11–25 (2021).

[29] Q. Qu, J. Zhang, X. Chen, H. Ravanbakhsh, G. Tang et al., Triggered release from cellulose microparticles inspired by wood degradation by fungi. ACS Sustain. Chem. Eng. 9(1), 387–397 (2021).

[30] Z. Zeng, M. Zhu, L. Chen, Y. Zhang, T. Lu et al., Design the molecule structures to achieve functional advantages of hydrogel wound dressings: advances and strategies. Compos. B Eng. 247, 110313 (2022).

[31] X. Liu, Q. Liu, X. He, G. Yang, X. Chen et al., NIR-II-enhanced single-atom-nanozyme for sustainable accelerating bacteria-infected wound healing. Appl. Surf. Sci. 612, 155866 (2023).

[32] C. Peng, R. Pang, J. Li, E. Wang, Current advances on the single-atom nanozyme and its bioapplications. Adv. Mater. (2023).

[33] T. Hu, Z. Gu, G.R. Williams, M. Strimaite, J. Zha et al., Layered double hydroxide-based nanomaterials for biomedical applications. Chem. Soc. Rev. 51(14), 6126–6176 (2022).

[34] X. Zhou, S. Zhang, Y. Liu, J. Meng, M. Wang et al., Antibacterial cascade catalytic glutathione-depleting MOF nanoreactors. ACS Appl. Mater. Interfaces 14(9), 11104–11115 (2022).

[35] R. Zeng, Y. Li, X. Hu, W. Wang, Y. Li et al., Atomically site synergistic effects of dual-atom nanozyme enhances peroxidase-like properties. Nano Lett. 23(13), 6073–6080 (2023).

[36] L. Chen, F. Wu, Y. Pang, D. Yan, S. Zhang et al., Therapeutic nanocoating of ocular surface. Nano Today 41, 101309 (2021).

[37] Z. Li, R. Liu, Q. Ma, X. Yu, Z. Xu et al., Eyeliner tattoos disturb ocular surface homeostasis. Ocul. Surf. 23, 216–218 (2022).

[38] H. Ou, Y. Qian, L. Yuan, H. Li, L. Zhang et al., Spatial position regulation of Cu single atom site realizes efficient nanozyme photocatalytic bactericidal activity. Adv. Mater. 35(46), e2305077 (2023).

[39] X. Dai, H. Liu, B. Cai, Y. Liu, K. Song et al., A bioinspired atomically thin nanodot supported single-atom nanozyme for antibacterial textile coating. Small 19(47), e2303901 (2023).

[40] C.-C. Hou, L. Zou, L. Sun, K. Zhang, Z. Liu et al., Single-atom iron catalysts on overhang-eave carbon cages for high-performance oxygen reduction reaction. Angew. Chem. Int. Ed. 59(19), 7384–7389 (2020).

[41] W. Feng, X. Han, H. Hu, M. Chang, L. Ding et al., 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases. Nat. Commun. 12, 2203 (2021).

[42] N.K. Campbell, H.K. Fitzgerald, A. Dunne, Regulation of inflammation by the antioxidant haem oxygenase 1. Nat. Rev. Immunol. 21, 411–425 (2021).

[43] H. Xian, K. Watari, E. Sanchez-Lopez, J. Offenberger, J. Onyuru et al., Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity 55(8), 1370-1385.e8 (2022).

[44] R. Zhang, M. Park, A. Richardson, N. Tedla, E. Pandzic et al., Dose-dependent benzalkonium chloride toxicity imparts ocular surface epithelial changes with features of dry eye disease. Ocul. Surf. 18(1), 158–169 (2020).

[45] L. García-Posadas, R.R. Hodges, D. Li, M.A. Shatos, T. Storr-Paulsen et al., Interaction of IFN-γ with cholinergic agonists to modulate rat and human goblet cell function. Mucosal Immunol. 9(1), 206–217 (2016).

[46] Y. Dai, J. Zhang, J. Xiang, Y. Li, D. Wu et al., Calcitriol inhibits ROS-NLRP3-IL-1β signaling axis via activation of Nrf2-antioxidant signaling in hyperosmotic stress stimulated human corneal epithelial cells. Redox Biol. 21, 101093 (2019).

微信扫一扫：分享

微信扫一扫：分享